Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 3.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 003386 | Roy M. Fleischmann [États-Unis, Afrique du Sud, Pologne, Mexique, Royaume-Uni] ; Anne-Marie Halland ; Marek Brzosko ; Ruben Burgos-Vargas ; Christopher Mela ; Emma Vernon ; Joel M. Kremer | Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results |
| 003B71 | Joel M. Kremer [États-Unis] ; Ricardo Blanco [Espagne] ; Marek Brzosko [Pologne] ; Ruben Burgos-Vargas [Mexique] ; Anne-Marie Halland [Afrique du Sud] ; Emma Vernon [Royaume-Uni] ; Petra Ambs [Suisse] ; Roy Fleischmann [États-Unis] | Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate: Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year |
| 004439 | Joel M. Kremer [États-Unis] ; Ricardo Blanco [Espagne] ; Anne-Marie Halland [Afrique du Sud] ; Marek Brzosko [Pologne] ; Ruben Burgos-Vargas [Mexique] ; Christopher M. Mela [Royaume-Uni] ; Lucy Rowell [Royaume-Uni] ; Roy M. Fleischmann [États-Unis] | Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial. |
| This area was generated with Dilib version V0.6.34. |  |